Search research articles
Contact Us
Filters
Showing results (21-30 of 63) with videos related to
Page
of 7
Sort By:
Cancer Immunology Research
|
August 29, 2025
Spatiotemporal immune landscape and long-term immune memory in POLE-mutant endometrial cancer at the single-cell level
Koen Brummel, Marta Requesens, Nienke van Rooij, et al.
The Journal of Pathology
|
December 13, 2019
Interpretation of somatic POLE mutations in endometrial carcinoma
Alicia León-Castillo, Heidi Britton, Melissa K McConechy, et al.
Clinical Genitourinary Cancer
|
January 17, 2018
Changing Practice Evaluation-Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols-Experience From a Supraregional Center
Helen E J Tyrrell, David N Church, Johnson Joseph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 22, 2018
Adjuvant Treatment for <i>POLE</i> Proofreading Domain-Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
Inge C Van Gool, Emily Rayner, Elisabeth M Osse, et al.
Human Molecular Genetics
|
March 27, 2013
DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer
David N Church, Sarah E W Briggs, Claire Palles, et al.
ESMO Open
|
February 22, 2020
Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised study
David Lau, Eleftheria Kalaitzaki, David N Church, et al.
Genome Medicine
|
August 25, 2025
Replication-associated mechanisms contribute to an increased CpG > TpG mutation burden in mismatch repair-deficient cancers
Joseph C Ward, Ignacio Soriano, Steve Thorn, et al.
British Journal of Cancer
|
August 8, 2019
Tumour-infiltrating CD8<sup>+</sup> lymphocytes and colorectal cancer recurrence by tumour and nodal stage
Mark A Glaire, Enric Domingo, Anita Sveen, et al.
Nature Genetics
|
February 13, 2026
Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types
Andrew Everall, Avraam Tapinos, Aliah Hawari, et al.
British Journal of Cancer
|
September 25, 2019
Correction: Tumour-infiltrating CD8<sup>+</sup> lymphocytes and colorectal cancer recurrence by tumour and nodal stage
Mark A Glaire, Enric Domingo, Anita Sveen, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 63) with videos related to
Sort By:
Page
of 7
Cancer Immunology Research
|
August 29, 2025
Spatiotemporal immune landscape and long-term immune memory in POLE-mutant endometrial cancer at the single-cell level
Koen Brummel, Marta Requesens, Nienke van Rooij, et al.
The Journal of Pathology
|
December 13, 2019
Interpretation of somatic POLE mutations in endometrial carcinoma
Alicia León-Castillo, Heidi Britton, Melissa K McConechy, et al.
Clinical Genitourinary Cancer
|
January 17, 2018
Changing Practice Evaluation-Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols-Experience From a Supraregional Center
Helen E J Tyrrell, David N Church, Johnson Joseph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 22, 2018
Adjuvant Treatment for <i>POLE</i> Proofreading Domain-Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
Inge C Van Gool, Emily Rayner, Elisabeth M Osse, et al.
Human Molecular Genetics
|
March 27, 2013
DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer
David N Church, Sarah E W Briggs, Claire Palles, et al.
ESMO Open
|
February 22, 2020
Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised study
David Lau, Eleftheria Kalaitzaki, David N Church, et al.
Genome Medicine
|
August 25, 2025
Replication-associated mechanisms contribute to an increased CpG > TpG mutation burden in mismatch repair-deficient cancers
Joseph C Ward, Ignacio Soriano, Steve Thorn, et al.
British Journal of Cancer
|
August 8, 2019
Tumour-infiltrating CD8<sup>+</sup> lymphocytes and colorectal cancer recurrence by tumour and nodal stage
Mark A Glaire, Enric Domingo, Anita Sveen, et al.
Nature Genetics
|
February 13, 2026
Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types
Andrew Everall, Avraam Tapinos, Aliah Hawari, et al.
British Journal of Cancer
|
September 25, 2019
Correction: Tumour-infiltrating CD8<sup>+</sup> lymphocytes and colorectal cancer recurrence by tumour and nodal stage
Mark A Glaire, Enric Domingo, Anita Sveen, et al.
Page
of 7